February 2018
Providence Cancer Institute is currently conducting more than 160 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
A groundbreaking immunoradiotherapy study for newly diagnosed head and neck cancers
In a new study at Providence Cancer Institute, patients with newly diagnosed head and neck cancers will be treated with five days of radiation therapy, followed by immunotherapy and surgery. Da ta from pioneering studies by Marka Crittenden, M.D., Ph.D. , su ggest that radiation can boost responses to immunotherapy. The hopes are that the new approach will reduce distant metastases and will improve quality of life by reducing the duration of radiation and avoiding chemotherapy.

This trial is one of 20 immunotherapy studies currently enrolling patients with oral, head and neck cancers or multiple tumor types.
All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types.
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.